Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Gama de Abreu M et al. Vaporized perfluorohexane attenuates ventilator-induced lung injury in isolated, perfused rabbit lungs. 2005 Anesthesiology pmid:15731599
Lowenstein E and Zapol WM Protamine reactions, explosive mediator release, and pulmonary vasoconstriction. 1990 Anesthesiology pmid:2393123
Shayevitz JR et al. Inhalation anesthetics augment oxidant-induced pulmonary vasoconstriction: evidence for a membrane effect. 1985 Anesthesiology pmid:3933385
Munsterhjelm E et al. Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. 2005 Anesthesiology pmid:16192763
Hudson JC et al. Ibuprofen pretreatment inhibits prostacyclin release during abdominal exploration in aortic surgery. 1990 Anesthesiology pmid:2106806
Horiguchi T et al. Heparin-protamine complexes cause pulmonary hypertension in goats. 1995 Anesthesiology pmid:7574058
Hirakata H et al. Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro. 1999 Anesthesiology pmid:10551587
Heller A et al. Pancreatitis-associated protein protects the lung from leukocyte-induced injury. 1999 Anesthesiology pmid:10551593
Fratacci MD et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. 1991 Anesthesiology pmid:1741521
Kurrek MM et al. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. 1995 Anesthesiology pmid:7832299
Numano F et al. Antiaggregative aspirin dosage at the affected vessel wall. 1986 Angiology pmid:2876664
Bölke E et al. Changes of gut barrier function during anesthesia and cardiac surgery. 2001 Angiology pmid:11515987
Mikhailidis DP et al. Platelet function in patients admitted with a diagnosis of myocardial infarction. 1987 Angiology pmid:2880535
Vissinger H et al. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. 1993 Angiology pmid:8342880
Saitta A et al. Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery disease. 1998 Angiology pmid:9822043
Jean T and Bodinier MC Mediators involved in inflammation: effects of Daflon 500 mg on their release. 1994 Angiology pmid:8203787
Nichols WW et al. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist. 1989 Angiology pmid:2537051
Sinzinger H et al. Platelet half-life, plasma thromboxane B2 and circulating endothelial-cells in peripheral vascular disease. 1986 Angiology pmid:3954150
Nagano H et al. Cerebral microcirculatory changes after cerebral embolization induced by glass bead injection in rabbits. 1992 Angiology pmid:1632571
Takase B et al. Arachidonic acid metabolites in acute myocardial infarction. 1996 Angiology pmid:8686958
Oda H et al. Alcohol and coronary spasm. 1994 Angiology pmid:8129199
Kurita A et al. The effects of orally administered atenolol on the coronary hemodynamics and prostaglandin metabolism in angina pectoris patients. 1994 Angiology pmid:8129203
Fujinishi A et al. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease. 1997 Angiology pmid:9194537
Nishikata H et al. Induction of bronchial hyperresponsiveness by Bordetella bronchiseptica infection in dogs. 1989 Ann Allergy pmid:2643371
Kivioja A et al. Platelet activation during acute phase after multiple trauma. 1992 Ann Chir Gynaecol pmid:1456710
Lin TY et al. The effect of YAG laser anterior capsulotomy on prostaglandin concentration in aqueous humor. 1988 Ann Ophthalmol pmid:3400958
Mohri H and Ohkubo T Single-dose effect of enteric-coated aspirin on platelet function and thromboxane generation in middle-aged men. 1993 Ann Pharmacother pmid:8477113
Tanen DA et al. Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition. 2008 Ann Pharmacother pmid:18698012
Angel MF et al. The effect of prior elevation of skin flaps and ischemia on blood thromboxane levels. 1989 Ann Plast Surg pmid:2751221
Edstrom LE et al. Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition. 1988 Ann Plast Surg pmid:3281544
Paterson IS et al. Reperfusion plasma contains a neutrophil activator. 1993 Ann Vasc Surg pmid:8390848
Ascer E et al. Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion. 1992 Ann Vasc Surg pmid:1547081
Fukushima C et al. In vitro responses to antigen stimulation: comparison between human lung parenchyma resected from asthmatic patients and non-asthmatic patients. 1999 Ann. Allergy Asthma Immunol. pmid:10071522
Zhao Y et al. Effect of a Chinese herbal formula, Shi-Bi-Lin, on an experimental model of allergic rhinitis. 2006 Ann. Allergy Asthma Immunol. pmid:16802773
Fukushima C et al. Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma. 1998 Ann. Allergy Asthma Immunol. pmid:9532973
Takao A et al. Inhibitory effects of azelastine hydrochloride in alcohol-induced asthma. 1999 Ann. Allergy Asthma Immunol. pmid:10227338
Fukushima C et al. Inhibitory effect of thromboxane A2 synthetase inhibitor, DP-1904, on antigen-induced contraction of human lung parenchyma. 1996 Ann. Allergy Asthma Immunol. pmid:8970439
Morris RH and Davies GG Thin layer chromatographic identification of thromboxane B2 in serum, and platelet rich plasma stimulated by arachidonic acid and collagen. 1993 Ann. Clin. Biochem. pmid:8466155
Nordøy A Lipids and thrombogenesis. 1981 Ann. Clin. Res. pmid:7018362
Ylikorkala O Prostanoids in gynaecology. 1984 Ann. Clin. Res. pmid:6398666
Vapaatalo H et al. Prostanoids in blood pressure regulation and their role in the blood pressure lowering effects induced by changes in dietary fats. 1984 Ann. Clin. Res. pmid:6398981
Elias M et al. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue. 1992 Ann. Hematol. pmid:1379080
Lee M et al. Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury. 1994 Ann. Intern. Med. pmid:8273981
Whelton A et al. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. 1990 Ann. Intern. Med. pmid:2183665
Emanuelli G et al. [Effects of anti-adrenergic drugs on thrombin-induced platelet aggregation and thromboxane B2 production]. 1988 Oct-Dec Ann. Ital. Med. Int. pmid:3275193
Osterud B and Hansen JB Fatty acids, platelets and monocytes. Something to do with atherogenesis. 1989 Ann. Med. pmid:2923703
Pratico D et al. Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha. 1994 Ann. N. Y. Acad. Sci. pmid:7825834
Feuerstein G Eicosanoids in deteriorating stroke. Review of studies on the rabbit spinal cord ischemia and reperfusion model. 1989 Ann. N. Y. Acad. Sci. pmid:2774403
Panganamala RV and Cornwell DG The effects of vitamin E on arachidonic acid metabolism. 1982 Ann. N. Y. Acad. Sci. pmid:6816121
Hansen TN and Carpenter JF The role of platelets in chilling-induced injury. 1994 Ann. N. Y. Acad. Sci. pmid:8017779
Wong PY et al. The role of calmodulin in prostaglandin metabolism. 1980 Ann. N. Y. Acad. Sci. pmid:6940495
Gryglewski RJ et al. Prostacyclin, nitric oxide, and atherosclerosis. 1995 Ann. N. Y. Acad. Sci. pmid:7695165
Numano F et al. Prostacyclin and variant angina. 1985 Ann. N. Y. Acad. Sci. pmid:3865605
Jesse RL et al. Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. 1995 Ann. N. Y. Acad. Sci. pmid:8597466
Hartung HP et al. Substance P stimulates release of arachidonic acid cyclooxygenation products from primary culture rat astrocytes. 1988 Ann. N. Y. Acad. Sci. pmid:2462817
Takami M et al. Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma. 1991 Ann. N. Y. Acad. Sci. pmid:1952565
Crinnion JN et al. Neutrophils and the endothelium in post-ischemic alterations in skeletal muscle blood flow. 1994 Ann. N. Y. Acad. Sci. pmid:8030907
Elmadfa I et al. Influence of a single parenteral application of a 10% fish oil emulsion on plasma fatty acid pattern and the function of thrombocytes in young adult men. 1993 Ann. Nutr. Metab. pmid:8470873
Cunnane SC Vitamin E intake affects serum thromboxane and tissue essential fatty acid composition in the rat. 1988 Ann. Nutr. Metab. pmid:3214140
Quoc KP and Pascaud M Effects of dietary gamma-linolenic acid on the tissue phospholipid fatty acid composition and the synthesis of eicosanoids in rats. 1996 Ann. Nutr. Metab. pmid:8773734
Masi I et al. Diets rich in saturated, monounsaturated and polyunsaturated fatty acids differently affect plasma lipids, platelet and arterial wall eicosanoids in rabbits. 1986 Ann. Nutr. Metab. pmid:3513691
Ferry DR et al. A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints. 2000 Ann. Oncol. pmid:11061613
Diven WF et al. Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla. 1998 Ann. Otol. Rhinol. Laryngol. pmid:9525240
Herrick AL et al. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. 1996 Ann. Rheum. Dis. pmid:8712862
Tishler M et al. Salivary eicosanoid concentration in patients with Sjögren's syndrome. 1996 Ann. Rheum. Dis. pmid:8712887
Katz JM et al. Inhibition of prostaglandin action and bone resorption by copper. 1984 Ann. Rheum. Dis. pmid:6441529
Tsai CY et al. Effect of antibodies to double stranded DNA, purified from serum samples of patients with active systemic lupus erythematosus, on the glomerular mesangial cells. 1992 Ann. Rheum. Dis. pmid:1550397
Salmon JA et al. Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture. 1983 Ann. Rheum. Dis. pmid:6402992
Seitz M and Hunstein W Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus. 1985 Ann. Rheum. Dis. pmid:4026405
Doube A et al. Effect of misoprostol on concentrations of prostaglandins in synovial fluid. 1991 Ann. Rheum. Dis. pmid:1772296
Taha AS et al. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. 1990 Ann. Rheum. Dis. pmid:2143369
Welbourn R et al. Involvement of thromboxane and neutrophils in multiple-system organ edema with interleukin-2. 1990 Ann. Surg. pmid:2256765
Fletcher JR et al. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia. 1990 Ann. Surg. pmid:2178565
Anner H et al. Pulmonary hypertension and leukosequestration after lower torso ischemia. 1987 Ann. Surg. pmid:3675025
Klausner JM et al. The rapid induction by interleukin-2 of pulmonary microvascular permeability. 1989 Ann. Surg. pmid:2783363
Huval WV et al. Role of serotonin in patients with acute respiratory failure. 1984 Ann. Surg. pmid:6547816
Utsunomiya T et al. Maintenance of cardiodynamics with aspirin during abdominal aortic aneurysmectomy (AAA). 1981 Ann. Surg. pmid:6117260
Mackey WC et al. Aspirin decreases platelet uptake on Dacron vascular grafts in baboons. 1984 Ann. Surg. pmid:6233945
Myers SI et al. Reperfusion inhibits elevated splanchnic prostanoid production after hemorrhagic shock. 1990 Ann. Surg. pmid:2256760
Paterson IS et al. Pulmonary edema after aneurysm surgery is modified by mannitol. 1989 Ann. Surg. pmid:2511812
Klausner JM et al. Limb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes. 1988 Ann. Surg. pmid:3196098
Klausner JM et al. Lower torso ischemia-induced lung injury is leukocyte dependent. 1988 Ann. Surg. pmid:3196099
Fletcher JR et al. Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. 1993 Ann. Surg. pmid:8507112
Valeri CR et al. Hypothermia-induced reversible platelet dysfunction. 1987 Ann. Surg. pmid:3813688
Rivkind AI et al. Sequential patterns of eicosanoid, platelet, and neutrophil interactions in the evolution of the fulminant post-traumatic adult respiratory distress syndrome. 1989 Ann. Surg. pmid:2549891
Klausner JM et al. Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited. 1989 Ann. Surg. pmid:2644899
Gottlieb A et al. The role of prostacyclin in the mesenteric traction syndrome during anesthesia for abdominal aortic reconstructive surgery. 1989 Ann. Surg. pmid:2647052
Lelcuk S et al. Thromboxane A2 moderates permeability after limb ischemia. 1985 Ann. Surg. pmid:3840349
Welbourn R et al. Interleukin-2 induces early multisystem organ edema mediated by neutrophils. 1991 Ann. Surg. pmid:1867524
Karwande SV et al. Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis. 1987 Ann. Thorac. Surg. pmid:3548616
DiSesa VJ et al. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization. 1984 Ann. Thorac. Surg. pmid:6388516
DeCampli WM et al. Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs. 1986 Ann. Thorac. Surg. pmid:3789860
Mainwaring RD et al. Complement activation and cytokine generation after modified Fontan procedure. 1998 Ann. Thorac. Surg. pmid:9647087
Tabuchi N et al. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass. 1994 Ann. Thorac. Surg. pmid:7524460
Lappegård KT et al. Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production. 2005 Ann. Thorac. Surg. pmid:15734405
Teoh KH et al. Blood conservation with membrane oxygenators and dipyridamole. 1987 Ann. Thorac. Surg. pmid:3300583
Hashimoto K et al. Perfusion pressure control by adenosine triphosphate given during cardiopulmonary bypass. 1993 Ann. Thorac. Surg. pmid:8417658
Schönberger JP et al. Systemic blood activation during and after autotransfusion. 1994 Ann. Thorac. Surg. pmid:8179396
Erez E et al. Thromboxane production in human lung during cardiopulmonary bypass: beneficial effect of aspirin? 1998 Ann. Thorac. Surg. pmid:9456103
Chiba Y et al. Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass. 1998 Ann. Thorac. Surg. pmid:9456104